Biofrontera
(NASDAQ) BFRI
Biofrontera Financials at a Glance
Market Cap
$13.19M
Revenue (TTM)
$43.20M
Net Income (TTM)
-$11.09M
EPS (TTM)
-$1.11
P/E Ratio
-0.93
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.03
Volume
299,864
Open
$1.09
Price
$1.03
Volume
299,864
Open
$1.09
Previous Close
$1.03
Daily Range
$1.02 - $1.10
52-Week Range
$0.55 - $1.19
Estimated Earnings Date
May 8, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.03
Volume
299,864
Open
$1.09
Previous Close
$1.03
Daily Range
$1.02 - $1.10
52-Week Range
$0.55 - $1.19
Estimated Earnings Date
May 8, 2026
BFRI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biofrontera
Industry
Pharmaceuticals
Sector
Health CareEmployees
92
CEO
Hermann Lübbert, PhD
Website
www.biofrontera-us.comHeadquarters
Woburn, MA 01801, US
BFRI Financials
Key Financial Metrics (TTM)
Gross Margin
82.79%
Operating Margin
-20.64%
Net Income Margin
-25.66%
Return on Equity
-476.72%
Return on Capital
-54.97%
Return on Assets
-44.72%
Earnings Yield
-1.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$13.19M
Shares Outstanding
12.80M
Volume
299.86K
Avg. Volume
194.86K
Financials (TTM)
Gross Profit
$35.77M
Operating Income
-$8.92M
EBITDA
-$10.00M
Operating Cash Flow
-$9.31M
Capital Expenditure
-$4.00K
Free Cash Flow
-$9.32M
Cash & ST Invst.
$6.32M
Total Debt
$7.72M
Biofrontera Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.08M
+17.4%
Gross Profit
$8.25M
+56.0%
Gross Margin
81.84%
N/A
Market Cap
$13.19M
N/A
Market Cap/Employee
$143.34K
N/A
Employees
92
N/A
Net Income
-$4.75M
-13.1%
EBITDA
-$4.69M
-21.3%
Quarterly Fundamentals
Total Cash
$6.32M
+252.5%
Total Debt
$7.72M
+58.8%
Accounts Receivable
$3.88M
-3.8%
Inventory
$1.23M
-81.1%
Long Term Debt
$7.22M
+62.7%
Short Term Debt
$506.00K
+18.8%
Return on Assets
-44.72%
N/A
Return on Invested Capital
-64.33%
N/A
Free Cash Flow
-$75.00K
+98.2%
Operating Cash Flow
-$70.00K
+98.3%